293 related articles for article (PubMed ID: 19734942)
1. RNA aptamers interfering with nucleophosmin oligomerization induce apoptosis of cancer cells.
Jian Y; Gao Z; Sun J; Shen Q; Feng F; Jing Y; Yang C
Oncogene; 2009 Nov; 28(47):4201-11. PubMed ID: 19734942
[TBL] [Abstract][Full Text] [Related]
2. Nucleophosmin is required for DNA integrity and p19Arf protein stability.
Colombo E; Bonetti P; Lazzerini Denchi E; Martinelli P; Zamponi R; Marine JC; Helin K; Falini B; Pelicci PG
Mol Cell Biol; 2005 Oct; 25(20):8874-86. PubMed ID: 16199867
[TBL] [Abstract][Full Text] [Related]
3. Negative regulation of p53 by nucleophosmin antagonizes stress-induced apoptosis in human normal and malignant hematopoietic cells.
Li J; Zhang X; Sejas DP; Pang Q
Leuk Res; 2005 Dec; 29(12):1415-23. PubMed ID: 15964625
[TBL] [Abstract][Full Text] [Related]
4. NSC348884, a nucleophosmin inhibitor disrupts oligomer formation and induces apoptosis in human cancer cells.
Qi W; Shakalya K; Stejskal A; Goldman A; Beeck S; Cooke L; Mahadevan D
Oncogene; 2008 Jul; 27(30):4210-20. PubMed ID: 18345031
[TBL] [Abstract][Full Text] [Related]
5. Applications of aptamers in cancer cell biology.
Phillips JA; Lopez-Colon D; Zhu Z; Xu Y; Tan W
Anal Chim Acta; 2008 Jul; 621(2):101-8. PubMed ID: 18573375
[TBL] [Abstract][Full Text] [Related]
6. SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands.
Stoltenburg R; Reinemann C; Strehlitz B
Biomol Eng; 2007 Oct; 24(4):381-403. PubMed ID: 17627883
[TBL] [Abstract][Full Text] [Related]
7. Binding to nucleophosmin determines the localization of human and chicken ARF but not its impact on p53.
Moulin S; Llanos S; Kim SH; Peters G
Oncogene; 2008 Apr; 27(17):2382-9. PubMed ID: 17968318
[TBL] [Abstract][Full Text] [Related]
8. Disease-specific biomarker discovery by aptamers.
Ulrich H; Wrenger C
Cytometry A; 2009 Sep; 75(9):727-33. PubMed ID: 19565638
[TBL] [Abstract][Full Text] [Related]
9. Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function.
Korgaonkar C; Hagen J; Tompkins V; Frazier AA; Allamargot C; Quelle FW; Quelle DE
Mol Cell Biol; 2005 Feb; 25(4):1258-71. PubMed ID: 15684379
[TBL] [Abstract][Full Text] [Related]
10. Complex target SELEX.
Shamah SM; Healy JM; Cload ST
Acc Chem Res; 2008 Jan; 41(1):130-8. PubMed ID: 18193823
[TBL] [Abstract][Full Text] [Related]
11. Nucleophosmin regulates the stability and transcriptional activity of p53.
Colombo E; Marine JC; Danovi D; Falini B; Pelicci PG
Nat Cell Biol; 2002 Jul; 4(7):529-33. PubMed ID: 12080348
[TBL] [Abstract][Full Text] [Related]
12. Delocalization and destabilization of the Arf tumor suppressor by the leukemia-associated NPM mutant.
Colombo E; Martinelli P; Zamponi R; Shing DC; Bonetti P; Luzi L; Volorio S; Bernard L; Pruneri G; Alcalay M; Pelicci PG
Cancer Res; 2006 Mar; 66(6):3044-50. PubMed ID: 16540653
[TBL] [Abstract][Full Text] [Related]
13. DNA damage, p14ARF, nucleophosmin (NPM/B23), and cancer.
Gjerset RA
J Mol Histol; 2006 Sep; 37(5-7):239-51. PubMed ID: 16855788
[TBL] [Abstract][Full Text] [Related]
14. Advances in SELEX and application of aptamers in the central nervous system.
Yang Y; Yang D; Schluesener HJ; Zhang Z
Biomol Eng; 2007 Dec; 24(6):583-92. PubMed ID: 17681489
[TBL] [Abstract][Full Text] [Related]
15. Effective isolation of RNA aptamer through suppression of PCR bias.
Tsuji S; Hirabayashi N; Kato S; Akitomi J; Egashira H; Tanaka T; Waga I; Ohtsu T
Biochem Biophys Res Commun; 2009 Aug; 386(1):223-6. PubMed ID: 19520057
[TBL] [Abstract][Full Text] [Related]
16. Selection of aptamers for molecular recognition and characterization of cancer cells.
Tang Z; Shangguan D; Wang K; Shi H; Sefah K; Mallikratchy P; Chen HW; Li Y; Tan W
Anal Chem; 2007 Jul; 79(13):4900-7. PubMed ID: 17530817
[TBL] [Abstract][Full Text] [Related]
17. The N-terminal half of NPM dissociates from nucleoli of HeLa cells after anticancer drug treatments.
Chan PK; Bloom DA; Hoang TT
Biochem Biophys Res Commun; 1999 Oct; 264(1):305-9. PubMed ID: 10527882
[TBL] [Abstract][Full Text] [Related]
18. Integrated microfluidic system for rapid screening of CRP aptamers utilizing systematic evolution of ligands by exponential enrichment (SELEX).
Huang CJ; Lin HI; Shiesh SC; Lee GB
Biosens Bioelectron; 2010 Mar; 25(7):1761-6. PubMed ID: 20061133
[TBL] [Abstract][Full Text] [Related]
19. [Current reviews in aptamers].
Wang C; Mo Z
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Apr; 23(2):463-6. PubMed ID: 16706390
[TBL] [Abstract][Full Text] [Related]
20. Nucleic acid aptamers targeting cell-surface proteins.
Dua P; Kim S; Lee DK
Methods; 2011 Jun; 54(2):215-25. PubMed ID: 21300154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
